Manipulation of hematopoietic cell development by expression of transcription factors
通过转录因子的表达调控造血细胞发育
基本信息
- 批准号:12670301
- 负责人:
- 金额:$ 2.18万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2000
- 资助国家:日本
- 起止时间:2000 至 2001
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
We have been proposing a hypothesis that the primitive hematopoietic cell lineage diverges directly from lateral mesoderm whereas the definitive hematopoietic cell lineage originates from the endothelial cell lineage which is another descendant of mesoderm. In this project, we analyzed expression and function of transcription factors which are thought to play important roles in hematopoietic cell development by using an in vitro differentiation system of mouse ES cells.We produced ES cell clones which revealed activity of the Gatal and Gata2 genes by expressing a GFP transgene as a marker. Expression of the Gata2 gene was already detected in a fraction of the earliest lateral mesoderm cells developed in a culture of the ES cells (day 3). The Gata2-expressing mesoderm cells purified by FACS from day 4 cultures exclusively contained primitive erythroid colony-forming cells (CFU-EryP) as well as stromal cell-dependent progenitors for definitive hematopoietic cells. On the other hand, expr … More ession of the Gatal gene in mesoderm cells became detectable after 4 days of ES cell differentiation. CFU-EryP was highly enriched in the Gata1-expressing mesoderm cell fraction. Mesoderm cells which have not started expression of the Gata1 gene by day 4 contained high frequency of endothelial cell progenitors. Endothelial cells derived from the progenitors possessed a potential to give rise to definitive hematopoietic cells.We next introduced an estrogen receptor/Cre-mediated inducible Tal1 transgene into an ES cell clone which is deficient for the endogenous Tall gene. By rescuing Tal1 expression in various stages of ES cell differentiation, we demonstrated that mesoderm cells require Tal1 at a period between day 3 and day 4 for the development of not only CFU-EryP but also hematogenic endothelial cells. Furthermore, overexpression of Tal1 in wild type ES cells resulted in an increase of Gata1-expressing mesoderm cells. The results collectively suggest that Tal1 and Gata2 are the prerequisite for the initiation of hematopoietic cell lineages. Less
我们提出了一个假设,即原始造血细胞系直接从侧中胚层分化,而定形造血细胞系起源于内皮细胞系,这是中胚层的另一个后代。本课题利用小鼠ES细胞的体外分化系统,分析了在造血细胞发育中发挥重要作用的转录因子的表达和功能。通过表达GFP转基因作为标记,获得了显示Gatal和Gata 2基因活性的ES细胞克隆。Gata 2基因的表达已经在ES细胞培养物中发育的最早的侧中胚层细胞的一部分中检测到(第3天)。通过FACS从第4天培养物纯化的表达Gata 2的中胚层细胞仅含有原始红系集落形成细胞(CFU-EryP)以及永久造血细胞的基质细胞依赖性祖细胞。另一方面,expr ...更多信息 在ES细胞分化4天后,中胚层细胞中Gatal基因的表达变得可检测。CFU-EryP在表达Gata 1的中胚层细胞组分中高度富集。到第4天还没有开始表达Gata 1基因的中胚层细胞含有高频率的内皮细胞祖细胞。内皮细胞来源于祖细胞具有潜力,产生永久hematopoietic cells.我们接下来引入了雌激素受体/Cre介导的诱导型Tal 1转基因到ES细胞克隆,这是缺乏内源性Tall基因。通过挽救Tal 1在ES细胞分化的各个阶段的表达,我们证明了中胚层细胞在第3天和第4天之间的时期需要Tal 1,不仅用于CFU-EryP的发育,而且用于造血内皮细胞的发育。此外,在野生型ES细胞中过表达Tal 1导致表达Gata 1的中胚层细胞增加。这些结果共同表明,Tal 1和Gata 2是造血细胞谱系启动的先决条件。少
项目成果
期刊论文数量(22)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
小川 峰太郎: "Origin of hematopoietic progenitors during embryogenesis"International Reviews of Immunology. 20. 23-46 (2000)
小川峰太郎:“胚胎发生过程中造血祖细胞的起源”《国际免疫学评论》20. 23-46 (2000)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
邊見 弘明: "Skin antigens in the steady state are trafficked to regional lymph nodes by transforming growth factor-β1-dependent cells"International Immunology. 13. 695-704 (2001)
Hiroaki Bemi:“稳定状态的皮肤抗原通过转化生长因子-β1依赖性细胞被运输到区域淋巴结”国际免疫学13. 695-704 (2001)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
横溝 智雅: "Requirement of Runx1/AML1/PEBP2αB for the generation of hematopoietic cells from endothelial cells"Genes to Cells. 6. 13-23 (2001)
Tomomasa Yokomizo:“从内皮细胞生成造血细胞的 Runx1/AML1/PEBP2αB 的要求”《基因到细胞》(Genes to Cell)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Stuart Fraser: "Embryonic stem cell differentiation as a model to study hematopoietic and endothelial cell development"Methods in Molecular Biology. 185. 71-81 (2001)
Stuart Fraser:“胚胎干细胞分化作为研究造血和内皮细胞发育的模型”分子生物学方法。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
宮下 浩輝: "A mouse orthologue of puromycin insensitive leucyl-specific aminopeptidase(PILSAP) is expressed in endothelial cell and plays an important role in angiogenesis"Blood. (印刷中).
Hiroki Miyashita:“嘌呤霉素不敏感亮氨酰特异性氨肽酶 (PILSAP) 的小鼠直系同源物在内皮细胞中表达,并在血管生成中发挥重要作用”血液。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
OGAWA Minetaro其他文献
OGAWA Minetaro的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('OGAWA Minetaro', 18)}}的其他基金
Controlling the differentiation of hemogenic endothelial cells: Toward the derivation of hematopoietic stem cells from ES cells
控制造血内皮细胞的分化:从 ES 细胞衍生造血干细胞
- 批准号:
15K07081 - 财政年份:2015
- 资助金额:
$ 2.18万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Induction of hematopoietic stem cells from ES/iPS cellswithout gene manipulation
无需基因操作即可从 ES/iPS 细胞诱导造血干细胞
- 批准号:
24657157 - 财政年份:2012
- 资助金额:
$ 2.18万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Regulation of angiogenesis by FOXO transcription factors
FOXO 转录因子对血管生成的调节
- 批准号:
21570229 - 财政年份:2009
- 资助金额:
$ 2.18万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Induction of cardio-vascular progenitor cells and blood vessel formation by ES cell differentiation.
通过 ES 细胞分化诱导心血管祖细胞和血管形成。
- 批准号:
16390227 - 财政年份:2004
- 资助金额:
$ 2.18万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Cell biological analyses of vascular remodeling by using an in vitro differentiation system of ES cells
使用 ES 细胞体外分化系统进行血管重塑的细胞生物学分析
- 批准号:
14570658 - 财政年份:2002
- 资助金额:
$ 2.18万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
Cooperation between lymphatic stroma and hematopoietic cells shapes protective immunity
淋巴基质和造血细胞之间的合作形成保护性免疫
- 批准号:
10724082 - 财政年份:2022
- 资助金额:
$ 2.18万 - 项目类别:
Developing a novel ex vivo platform to support hematopoietic cells and characterize the stem cell niche
开发新型离体平台来支持造血细胞并表征干细胞生态位
- 批准号:
10482424 - 财政年份:2020
- 资助金额:
$ 2.18万 - 项目类别:
Developing a novel ex vivo platform to support hematopoietic cells and characterize the stem cell niche
开发新型离体平台来支持造血细胞并表征干细胞生态位
- 批准号:
10684323 - 财政年份:2020
- 资助金额:
$ 2.18万 - 项目类别:
Developing a novel ex vivo platform to support hematopoietic cells and characterize the stem cell niche
开发新型离体平台来支持造血细胞并表征干细胞生态位
- 批准号:
10364610 - 财政年份:2020
- 资助金额:
$ 2.18万 - 项目类别:
Mechanisms of Human Cytomegalovirus Latency in Primary Human Hematopoietic Cells
人原代造血细胞中人巨细胞病毒潜伏期的机制
- 批准号:
10542647 - 财政年份:2019
- 资助金额:
$ 2.18万 - 项目类别:
Mechanisms of Human Cytomegalovirus Latency in Primary Human Hematopoietic Cells
人原代造血细胞中人巨细胞病毒潜伏期的机制
- 批准号:
10020896 - 财政年份:2019
- 资助金额:
$ 2.18万 - 项目类别:
Mechanisms of Human Cytomegalovirus Latency in Primary Human Hematopoietic Cells
人原代造血细胞中人巨细胞病毒潜伏期的机制
- 批准号:
10475998 - 财政年份:2019
- 资助金额:
$ 2.18万 - 项目类别:
Differences in Sfpi1 gene deletion in hematopoietic cells after repeated low-dose X-ray partial irradiation
重复低剂量X射线部分照射后造血细胞Sfpi1基因缺失的差异
- 批准号:
19K20451 - 财政年份:2019
- 资助金额:
$ 2.18万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of iron-sulfur proteins in hematopoietic cells through anamorsin
通过阿莫辛评价造血细胞中的铁硫蛋白
- 批准号:
19K08861 - 财政年份:2019
- 资助金额:
$ 2.18万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Mechanisms of Human Cytomegalovirus Latency in Primary Human Hematopoietic Cells
人原代造血细胞中人巨细胞病毒潜伏期的机制
- 批准号:
9916085 - 财政年份:2019
- 资助金额:
$ 2.18万 - 项目类别: